“Sglt-2 Inhibitors in Diabetic Type 2 Patients Nephroprotective Effects of (Empagliflozin)”. Eurasian Journal of Research, Development and Innovation 26 (November 6, 2023): 1–4. Accessed June 18, 2026. https://mail.geniusjournals.org/index.php/ejrdi/article/view/5178.